This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Mark Your Calendar for BPI US West 2023!
February 27 - March 3, 2023San Diego Convention Center

Keith Wilson
Director, Manufacturing Science and Technology at Century Therapeutics, Inc., USA


Keith has 15 years of industry experience in the cell therapy development and operations space. He is currently the Director of Manufacturing Science and Technology (MSAT) at Century Therapeutics, leading the implementation, support, and scale up of Century’s manufacturing processes into a new in-house facility. Prior to Century, Keith was at Celgene/ Bristol Myers Squibb for 14 years in the cell therapy space. He most recently led the clinical manufacturing team in successful execution of a pivotal CAR T trial, as well as several Phase I trials. Prior to that he held roles of increasing responsibility in Process Development and tech transfer, with expertise in both autologous and allogenic cell therapies, across multiple cell types. Keith received his Masters and Bachelors of Biomedical Engineering at Stevens Institute of Technology in Hoboken, NJ.

Agenda Sessions

  • Allogeneic Cell Therapy Process Development Considerations for Low Volume Dosage Indications